Меню
Набор скоро начнётся NCT07281547

Low Dose Aspirin to Lower Inflammation and Prevent Endometrial Cancer in Postmenopausal Women With Non-atrophic Endometrial Changes and Pain

Фаза IV С лечением Endometrial Carcinoma

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: Biospecimen Collection, Low-Dose Aspirin, Patient Observation, Questionnaire Administration.
Кому может быть актуально
Состояния в реестре: Endometrial Carcinoma. Базовые параметры: Без ограничений · Женщины.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
США
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →

Не всё понятно в терминах? Прочитайте наш гид для пациентов →

Официальное название

Mechanistic Randomized Controlled Feasibility Trial of Aspirin on Endometrium and Inflammatory Metabolites in Postmenopausal Women With Non-Atrophic Endometrial Changes

Обзор

This phase IV trial studies whether low dose aspirin can be used to lower inflammation and prevent endometrial cancer in postmenopausal women with changes in the endometrial tissue that are not related to thinning (non-atrophic endometrial changes) and pain. As people age, there is an accumulation of fats, cell death, and inflammation, which causes a surge of pro-cancer-causing events. It is thought that there are several factors involved in the development of endometrial cancer, but that managing the inflammation may address the root cause. Low dose aspirin is aspirin that contains a lower dose than a standard adult tablet. Aspirin is a drug that reduces pain, fever, inflammation, and blood clotting. Aspirin belongs to the family of drugs called nonsteroidal anti-inflammatory agents. It is also being studied in cancer prevention. Giving low dose aspirin may be an effective way to lower inflammation and prevent endometrial cancer in postmenopausal women with non-atrophic endometrial changes and pain.

Вмешательства

  • Процедура Biospecimen Collection
    Undergo blood, urine, and endometrial tissue sample collection
  • Препарат Low-Dose Aspirin
    Given PO
  • Другое Patient Observation
    Undergo observation
  • Другое Questionnaire Administration
    Ancillary studies
  • Процедура Ultrasound Imaging
    Undergo pelvic ultrasound

Первичные конечные точки

  • Change in prostaglandin E2 (PGE2) [Срок оценки: Baseline to 6 weeks]
Вторичные конечные точки (1)
  • Facilitators and Barriers to Participating in a Clinical Trial After Consenting to Clinical Trial [Срок оценки: Baseline to 6 weeks]

Критерии участия

Критерии включения

  • PRE-REGISTRATION: Postmenopausal women
  • PRE-REGISTRATION: Transvaginal ultrasound
  • PRE-REGISTRATION: Scheduled endometrial biopsy
  • PRE-REGISTRATION: Provide risk factor survey
  • REGISTRATION: Postmenopausal (defined clinically by no period for over 1 year or postmenopausal follicle-stimulating hormone \[FSH\], estradiol, or anti-Mullerian hormone \[AMH\] levels due to natural, medical, or surgical causes)
  • REGISTRATION: Have pain (an indicator of inflammation) and other findings warranting endometrial sampling (postmenopausal bleeding \[PMB\], incidentally noted thickened endometrium > 4mm on ultrasound, obesity, fibroids)
  • REGISTRATION: Capable of providing informed consent
  • REGISTRATION: Understands English or Spanish language for consent and questionnaires
  • REGISTRATION: Ability to complete questionnaire(s) by themselves or with assistance
  • REGISTRATION: Willingness to provide mandatory blood specimens for correlative research
  • REGISTRATION: Willingness to provide mandatory tissue specimens for correlative research
  • REGISTRATION: Willingness to provide mandatory urine sample for correlative research

Критерии исключения

  • PRE-REGISTRATION: Not postmenopausal person born with uterus
  • PRE-REGISTRATION: Atrophic endometrium
  • PRE-REGISTRATION: No uterus
  • PRE-REGISTRATION: Malignancy found
  • REGISTRATION: Patients with previous hysterectomy (removal of the uterus)
  • REGISTRATION: Atrophic endometrium on endometrial sampling performed clinically
  • REGISTRATION: Patients from outside the Mayo Clinic Comprehensive Cancer Center (MCCCC) area
  • REGISTRATION: Clinically contraindicated to discontinue use of anticoagulation other than aspirin
  • REGISTRATION: Contraindication to use of nonsteroidal anti-inflammatory drugs (NSAIDs) or previous adverse reaction or intolerance to NSAIDs
  • REGISTRATION: History of uterine, cervical, or ovarian cancers or precancers (endometrial hyperplasia, cervical dysplasia, fallopian tube intraepithelial carcinoma)

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Да

Дизайн исследования

Распределение
Рандомизированное
Модель
Параллельные группы
Маскирование
Открытое
Основная цель
Профилактика

Центры проведения

США · 1 центр
  • Mayo Clinic in Florida — Jacksonville

Идентификаторы

NCT: NCT07281547 · MC240602 · 24-006515

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗